OpenAI

  • This Isn’t Rogue AI. It’s the Most Human Thing We’ve Built.

    This Isn’t Rogue AI. It’s the Most Human Thing We’ve Built.

    Prohibition banned alcohol nationwide, so people built bathtub gins, speakeasies, and a smuggling network that made a generation of bootleggers rich. The Berlin Wall was built specifically to stop people from leaving, and people still went over it, under it, through sewer tunnels, in hot air balloons, hidden in car panels. Give a person a…

    read more

  • NVIDIA Bet $100 Billion on OpenAI. Who Pays If It’s Wrong?

    NVIDIA Bet $100 Billion on OpenAI. Who Pays If It’s Wrong?

    You’re holding something that didn’t have to exist. Not in the abstract way. In the literal way. Somebody looked at the world as it was and decided it wasn’t good enough, and bet on a different one. You don’t think about that most days. Why would you. The phone works. The chip is fast. You…

    read more

  • OpenAI Pledges to Cover Energy Costs Amid Trump’s Warning

    OpenAI Pledges to Cover Energy Costs Amid Trump’s Warning

    Following former President Trump’s calls for AI companies to cover their own energy costs, OpenAI has stepped up. The company announced it will fund its massive AI infrastructure expansion without relying on local communities. The centerpiece of this effort is Stargate, a $500 billion AI buildout backed by SoftBank, Oracle, MGX, and tech partners including…

    read more

  • OpenAI Rolls Out Ads on ChatGPT for Free Users

    OpenAI Rolls Out Ads on ChatGPT for Free Users

    OpenAI announced Friday that it plans to start testing advertisements on ChatGPT in the coming weeks. The company says this step is part of a strategy to cover the growing costs of running the world’s most popular AI chatbot. Initially, ads will appear only in the U.S. for free users and lower-tier subscribers. Premium Pro…

    read more

  • AI in Pharma Gets a $25M Shot in the Arm

    AI in Pharma Gets a $25M Shot in the Arm

    Converge Bio, a Boston- and Tel Aviv-based startup, raised $25 million in a Series A round. Bessemer Venture Partners led the round. TLV Partners, Vintage Investment Partners, and executives from Meta, OpenAI, and Wiz also joined. The company uses AI to help pharma and biotech companies develop drugs faster. The funding comes a year and…

    read more